Biomind Labs (NEOE:BMND) Accounts Payable & Accrued Expense : C$0.83 Mil (As of Sep. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Biomind Labs Accounts Payable & Accrued Expense?

Biomind Labs's quarterly accounts payable & accrued expense increased from Mar. 2023 (C$0.60 Mil) to Jun. 2023 (C$0.86 Mil) but then declined from Jun. 2023 (C$0.86 Mil) to Sep. 2023 (C$0.83 Mil).

Biomind Labs's annual accounts payable & accrued expense increased from . 20 (C$0.00 Mil) to Dec. 2021 (C$0.37 Mil) and increased from Dec. 2021 (C$0.37 Mil) to Dec. 2022 (C$0.45 Mil).

Biomind Labs Accounts Payable & Accrued Expense Historical Data

The historical data trend for Biomind Labs's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biomind Labs Accounts Payable & Accrued Expense Chart

Biomind Labs Annual Data

Trend

Dec21

Dec22

Accounts Payable & Accrued Expense

0.37

0.45

Biomind Labs Quarterly Data
	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial						0.39	0.45	0.60	0.86	0.83

Biomind Labs Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Biomind Labs (NEOE:BMND) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biomind Labs Inc (NEOE:BMND) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

3XI:Germany

Address

Camino Saravia s/n, Pando Science and Technology Park, Pando Canelones, Canelones, URY, CP 91.000

Website

https://www.biomindlabs.com

Biomind Labs Inc is a biotech Research and Development company aimed at transforming biomedical sciences knowledge from natural psychotropic plants into novel pharmaceutical drugs and nanotech delivery systems for a variety of psychiatric and neurological conditions. Biomind is developing pharmaceutical sole and combined formulations of the main natural psychedelic molecules with the aim of identifying novel pharmaceutical compounds for treating a wide range of therapeutic indications.

Biomind Labs (NEOE:BMND) Headlines

No Headlines